FLUTEMETAMOL F-18
| Brand name | VIZAMYL |
|---|---|
| Active ingredient | FLUTEMETAMOL F-18 |
| Strength | 121.5mCi/30ML (4.05mCi/ML) |
| Dosage form | INJECTABLE |
| Route | INTRAVENOUS |
| Modality | Small molecule |
| FDA approval | October 2013 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 8916131 | September 2028 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.